Solar power is the fastest growing part of the global energy industry. Inderpreet Wadhwa, CEO of Azure Power, one of the largest solar power producers in India, sat down with us to discuss why India is well positioned to capitalize on the trend.
Wadhwa emphasizes that over 200 million people in India do not have electricity. He says there is a lot of potential because solar radiation is available in most parts of the country, and India has over 300 days of sun. The fact that India is an emerging economy and has to build new infrastructure is another advantage, he says, because the country can "leapfrog" coal industry infrastructure.
For Azure Power, it is important to work closely with the government. Wadhwa says energy in India is highly regulated so they need favorable government policy. 90% of the company's contracts are with the government. With the price of solar much cheaper than energy consumed in many industries, Wadhwa says they are now doing more commercial contracts with industries such as the hotels.
Blame geography for the U.S. getting hit by stronger, costlier, more varied and frequent extreme weather than anywhere on the planet, several experts said. But that's only part of it.
Residents across a wide swath of the U.S. raced Sunday to assess the destruction from fierce storms that spawned possibly dozens of tornadoes from the South and the Midwest into the Northeast.
The U.S. Food and Drug Administration has approved selling overdose antidote naloxone over-the-counter, marking the first time a opioid treatment drug will be available without a prescription.
Millions of Americans could lose access to Medicaid on April 1, and Joe Dunn, senior vice president of public policy at the National Association of Community Health Centers, joined Cheddar News' anchor Shannon LaNier to discuss what this means for public health.
One third of Americans don't have access to primary care providers in their communities, according to a study from the National Association of Community Health Centers published last month.
Neuralink, Elon Musk's brain implant venture, is reaching out to major U.S. neurosurgery centers to potentially begin testing its devices on humans, according to a Reuters report.
